Wave Life Sciences
Top stories
- Tonix Pharmaceuticals (NASDAQ:TNXP) & WAVE Life Sciences (NASDAQ:WVE) Head to Head Contrast2 outlets · 2026-10-02 18:37 UTC
Latest
- Head-To-Head Review: WAVE Life Sciences (NASDAQ:WVE) versus Tonix Pharmaceuticals (NASDAQ:TNXP)tickerreport.com · 2026-10-02 18:37 UTC · 1 more reports
- WAVE Life Sciences Ltd. (NASDAQ:WVE) Stock Has Consensus Target Price of $22.31 According to Analystsdailypolitical.com · 2026-10-02 06:40 UTC · story
- Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATDmanilatimes.net · 2026-10-01 11:40 UTC · story
- Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further DevelopmentGlobeNewswire — public companies · 2026-09-30 11:30 UTC · story
- Critical Survey: WAVE Life Sciences (NASDAQ:WVE) versus Regeneron Pharmaceuticals (NASDAQ:REGN)tickerreport.com · 2026-09-27 14:10 UTC · story